CRMXvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with CRMX, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
CRMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CRMX ETF 2 | +69.56%– | -77.21%– | n/a– | n/a– | n/a– | n/a– |
| Flows | CRMX ETF 2 | +$8M– | +$29M– | -– | -– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CRMX ETF 2 | +286.92%– | n/a– | n/a– | n/a– |
| Max drawdown | CRMX ETF 2 | -90.76%– | n/a– | n/a– | n/a– |
| Max drawdown duration | CRMX ETF 2 | 88d– | n/a– | n/a– | n/a– |
Trading data
CRMX | ETF 2 | |
Last sale 4/24/2026 at 1:30 PM | $22.30 | – |
| Previous close 04/24/2026 | $19.30 | – |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Replication data will be available soon
Advertisement
Main metrics
Last update 4/24/2026 at 1:30 PM
Live
Closed
CRMX | ETF 2 | |
|---|---|---|
| Last price | $22.30 | – |
| 1D performance | +15.54% | – |
| AuM | $22.09 M | – |
| E/R | 1.49% | – |
Characteristics
CRMX | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | AXS Investments | – |
| Benchmark | CRML Price | – |
| N° of holdings | - | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 12, 2026 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
CRMX
Data will be available soon
ETF 2
Sectors
CRMX
Data will be available soon
ETF 2
Advertisement
Diversification
CRMX
Data will be available soon
ETF 2
–
Top 15 holdings
Data as of January 1, 1970
CRMX
Data will be available soon
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
